1,184.80
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NFLX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$1,208.55
Offen:
$1208
24-Stunden-Volumen:
498.45K
Relative Volume:
0.10
Marktkapitalisierung:
$504.44B
Einnahmen:
$40.17B
Nettoeinkommen (Verlust:
$9.27B
KGV:
55.99
EPS:
21.16
Netto-Cashflow:
$7.45B
1W Leistung:
-0.21%
1M Leistung:
+5.31%
6M Leistung:
+33.68%
1J Leistung:
+81.09%
Netflix Inc Stock (NFLX) Company Profile
Firmenname
Netflix Inc
Sektor
Branche
Telefon
408-540-3700
Adresse
121 ALBRIGHT WAY, LOS GATOS
Vergleichen Sie NFLX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
NFLX
Netflix Inc
|
1,185.33 | 508.40B | 40.17B | 9.27B | 7.45B | 21.16 |
![]()
DIS
Walt Disney Co
|
111.80 | 198.58B | 94.04B | 8.91B | 10.90B | 4.89 |
![]()
LYV
Live Nation Entertainment Inc
|
135.97 | 33.41B | 22.74B | 973.97M | 1.34B | 2.93 |
![]()
WBD
Warner Bros Discovery Inc
|
10.10 | 22.14B | 38.34B | -10.80B | 4.34B | -4.40 |
![]()
FWONK
Liberty Media Corp
|
95.61 | 24.37B | 3.51B | -102.00M | 737.00M | -0.42 |
Netflix Inc Stock (NFLX) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-05-19 | Herabstufung | JP Morgan | Overweight → Neutral |
2025-04-21 | Bestätigt | BMO Capital Markets | Outperform |
2025-04-21 | Bestätigt | Barclays | Equal Weight |
2025-04-21 | Bestätigt | Canaccord Genuity | Buy |
2025-04-21 | Bestätigt | Guggenheim | Buy |
2025-04-21 | Bestätigt | JP Morgan | Overweight |
2025-04-21 | Bestätigt | KeyBanc Capital Markets | Overweight |
2025-04-21 | Bestätigt | MoffettNathanson | Buy |
2025-04-21 | Bestätigt | Morgan Stanley | Overweight |
2025-04-21 | Bestätigt | Oppenheimer | Outperform |
2025-04-21 | Bestätigt | Piper Sandler | Overweight |
2025-04-21 | Bestätigt | Pivotal Research Group | Buy |
2025-04-21 | Bestätigt | Wells Fargo | Overweight |
2025-04-17 | Fortgesetzt | Piper Sandler | Overweight |
2025-03-27 | Eingeleitet | FBN Securities | Outperform |
2025-03-17 | Hochstufung | MoffettNathanson | Neutral → Buy |
2025-01-24 | Hochstufung | Bernstein | Mkt Perform → Outperform |
2025-01-23 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
2025-01-22 | Hochstufung | Barclays | Underweight → Equal Weight |
2025-01-22 | Hochstufung | Canaccord Genuity | Hold → Buy |
2025-01-22 | Bestätigt | Oppenheimer | Outperform |
2025-01-22 | Bestätigt | Pivotal Research Group | Buy |
2025-01-22 | Hochstufung | Rosenblatt | Neutral → Buy |
2025-01-22 | Hochstufung | The Benchmark Company | Sell → Hold |
2025-01-16 | Hochstufung | Seaport Research Partners | Neutral → Buy |
2025-01-15 | Bestätigt | BMO Capital Markets | Outperform |
2025-01-15 | Bestätigt | Oppenheimer | Outperform |
2025-01-08 | Bestätigt | Goldman | Neutral |
2025-01-06 | Bestätigt | Argus | Buy |
2025-01-03 | Bestätigt | The Benchmark Company | Sell |
2024-12-19 | Bestätigt | UBS | Buy |
2024-12-16 | Herabstufung | Loop Capital | Buy → Hold |
2024-12-16 | Bestätigt | Oppenheimer | Outperform |
2024-12-11 | Bestätigt | JP Morgan | Overweight |
2024-11-20 | Bestätigt | Pivotal Research Group | Buy |
2024-10-18 | Bestätigt | Needham | Buy |
2024-10-18 | Bestätigt | Oppenheimer | Outperform |
2024-10-18 | Bestätigt | Pivotal Research Group | Buy |
2024-10-16 | Bestätigt | Loop Capital | Buy |
2024-10-11 | Bestätigt | Guggenheim | Buy |
2024-10-10 | Bestätigt | Morgan Stanley | Overweight |
2024-10-10 | Bestätigt | Oppenheimer | Outperform |
2024-10-07 | Herabstufung | Barclays | Equal Weight → Underweight |
2024-10-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
2024-10-01 | Bestätigt | KeyBanc Capital Markets | Overweight |
2024-09-05 | Eingeleitet | China Renaissance | Hold |
2024-08-30 | Bestätigt | Pivotal Research Group | Buy |
2024-07-17 | Bestätigt | Guggenheim | Buy |
2024-07-16 | Bestätigt | The Benchmark Company | Sell |
2024-07-15 | Bestätigt | BofA Securities | Buy |
2024-07-12 | Bestätigt | JP Morgan | Overweight |
2024-07-10 | Bestätigt | KeyBanc Capital Markets | Overweight |
2024-07-09 | Bestätigt | TD Cowen | Buy |
2024-07-02 | Bestätigt | Argus | Buy |
2024-05-28 | Bestätigt | Evercore ISI | Outperform |
2024-04-19 | Herabstufung | Canaccord Genuity | Buy → Hold |
2024-04-19 | Hochstufung | Needham | Hold → Buy |
2024-04-19 | Bestätigt | Pivotal Research Group | Buy |
2024-04-15 | Bestätigt | Deutsche Bank | Hold |
2024-04-12 | Bestätigt | Morgan Stanley | Overweight |
2024-04-12 | Bestätigt | Piper Sandler | Neutral |
2024-04-05 | Bestätigt | Pivotal Research Group | Buy |
2024-03-25 | Bestätigt | Citigroup | Neutral |
2024-03-12 | Bestätigt | Jefferies | Buy |
2024-03-11 | Bestätigt | Oppenheimer | Outperform |
2024-01-30 | Herabstufung | Seaport Research Partners | Buy → Neutral |
2024-01-25 | Hochstufung | DZ Bank | Hold → Buy |
2024-01-24 | Bestätigt | BMO Capital Markets | Outperform |
2024-01-24 | Bestätigt | BofA Securities | Buy |
2024-01-24 | Bestätigt | Canaccord Genuity | Buy |
2024-01-24 | Bestätigt | Evercore ISI | Outperform |
2024-01-24 | Bestätigt | Goldman | Neutral |
2024-01-24 | Bestätigt | Guggenheim | Buy |
2024-01-24 | Bestätigt | JP Morgan | Overweight |
2024-01-24 | Bestätigt | KeyBanc Capital Markets | Overweight |
2024-01-24 | Hochstufung | Macquarie | Neutral → Outperform |
2024-01-24 | Bestätigt | Morgan Stanley | Overweight |
2024-01-24 | Bestätigt | Oppenheimer | Outperform |
2024-01-24 | Bestätigt | Piper Sandler | Neutral |
2024-01-24 | Bestätigt | Pivotal Research Group | Buy |
2024-01-24 | Bestätigt | Redburn Atlantic | Buy |
2024-01-24 | Bestätigt | Robert W. Baird | Outperform |
2024-01-24 | Bestätigt | TD Cowen | Outperform |
2024-01-24 | Bestätigt | UBS | Buy |
2024-01-24 | Bestätigt | Wells Fargo | Overweight |
2023-09-18 | Bestätigt | Evercore ISI | Outperform |
2023-08-25 | Hochstufung | Loop Capital | Hold → Buy |
2023-07-24 | Hochstufung | Robert W. Baird | Neutral → Outperform |
2023-07-17 | Bestätigt | Deutsche Bank | Buy |
2023-07-13 | Bestätigt | JP Morgan | Overweight |
2023-07-12 | Bestätigt | UBS | Buy |
2023-07-05 | Hochstufung | Goldman | Sell → Neutral |
2023-06-29 | Bestätigt | Citigroup | Buy |
2023-06-28 | Bestätigt | Oppenheimer | Outperform |
2023-06-13 | Bestätigt | BofA Securities | Buy |
2023-06-13 | Bestätigt | Guggenheim | Buy |
2023-04-19 | Bestätigt | Deutsche Bank | Buy |
2023-04-19 | Bestätigt | JP Morgan | Overweight |
2023-04-19 | Bestätigt | Jefferies | Buy |
2023-04-19 | Bestätigt | Piper Sandler | Neutral |
2023-04-19 | Bestätigt | Pivotal Research Group | Buy |
2023-04-19 | Bestätigt | Rosenblatt | Neutral |
2023-04-19 | Hochstufung | UBS | Neutral → Buy |
2023-04-11 | Fortgesetzt | Robert W. Baird | Neutral |
2023-01-23 | Bestätigt | Argus | Buy |
2023-01-20 | Bestätigt | Canaccord Genuity | Buy |
2023-01-20 | Bestätigt | Deutsche Bank | Buy |
2023-01-20 | Bestätigt | Evercore ISI | Outperform |
2023-01-20 | Bestätigt | Goldman | Sell |
2023-01-20 | Bestätigt | Guggenheim | Buy |
2023-01-20 | Bestätigt | Jefferies | Buy |
2023-01-20 | Bestätigt | MoffettNathanson | Market Perform |
2023-01-20 | Bestätigt | Oppenheimer | Outperform |
2023-01-20 | Bestätigt | Piper Sandler | Neutral |
2023-01-20 | Bestätigt | Pivotal Research Group | Buy |
2023-01-20 | Bestätigt | Robert W. Baird | Neutral |
2023-01-20 | Bestätigt | The Benchmark Company | Sell |
2023-01-20 | Bestätigt | Wedbush | Outperform |
2023-01-20 | Bestätigt | Wolfe Research | Outperform |
2023-01-12 | Hochstufung | Jefferies | Hold → Buy |
2023-01-04 | Eingeleitet | New Street | Neutral |
2022-12-29 | Hochstufung | CFRA | Sell → Buy |
2022-12-14 | Bestätigt | Jefferies | Hold |
2022-12-09 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
2022-06-14 | Herabstufung | The Benchmark Company | Hold → Sell |
2022-06-10 | Herabstufung | Goldman | Neutral → Sell |
2022-05-16 | Hochstufung | Wedbush | Neutral → Outperform |
2022-04-21 | Herabstufung | DZ Bank | Buy → Hold |
2022-04-21 | Herabstufung | Edward Jones | Buy → Hold |
2022-04-20 | Herabstufung | Atlantic Equities | Overweight → Neutral |
2022-04-20 | Herabstufung | BofA Securities | Buy → Underperform |
2022-04-20 | Herabstufung | JP Morgan | Overweight → Neutral |
2022-04-20 | Hochstufung | Needham | Underperform → Hold |
2022-04-20 | Herabstufung | Oppenheimer | Outperform → Perform |
2022-04-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
2022-04-20 | Herabstufung | Pivotal Research Group | Buy → Sell |
2022-04-20 | Herabstufung | Stifel | Buy → Hold |
2022-04-20 | Herabstufung | UBS | Buy → Neutral |
2022-04-20 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
2022-04-19 | Eingeleitet | Rosenblatt | Neutral |
2022-03-09 | Hochstufung | Wedbush | Underperform → Neutral |
2022-01-31 | Hochstufung | Citigroup | Neutral → Buy |
2022-01-31 | Hochstufung | Edward Jones | Hold → Buy |
2022-01-24 | Herabstufung | Jefferies | Buy → Hold |
2022-01-21 | Bestätigt | BMO Capital Markets | Outperform |
2022-01-21 | Bestätigt | BofA Securities | Buy |
2022-01-21 | Bestätigt | Canaccord Genuity | Buy |
2022-01-21 | Bestätigt | Cowen | Outperform |
2022-01-21 | Bestätigt | Deutsche Bank | Hold |
2022-01-21 | Bestätigt | Goldman | Neutral |
2022-01-21 | Bestätigt | Guggenheim | Buy |
2022-01-21 | Bestätigt | JP Morgan | Overweight |
2022-01-21 | Bestätigt | MoffettNathanson | Neutral |
2022-01-21 | Herabstufung | Monness Crespi & Hardt | Buy → Neutral |
2022-01-21 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2022-01-21 | Bestätigt | Oppenheimer | Outperform |
2022-01-21 | Bestätigt | Piper Sandler | Overweight |
2022-01-21 | Bestätigt | Pivotal Research Group | Buy |
2022-01-21 | Herabstufung | Robert W. Baird | Outperform → Neutral |
2022-01-21 | Bestätigt | Stifel | Buy |
2022-01-21 | Hochstufung | The Benchmark Company | Sell → Hold |
2022-01-21 | Herabstufung | Truist | Buy → Hold |
2022-01-21 | Bestätigt | UBS | Buy |
2022-01-21 | Bestätigt | Wolfe Research | Outperform |
2021-12-15 | Bestätigt | The Benchmark Company | Sell |
2021-10-20 | Herabstufung | Deutsche Bank | Buy → Hold |
2021-10-20 | Bestätigt | Monness Crespi & Hardt | Buy |
2021-09-29 | Bestätigt | The Benchmark Company | Sell |
2021-09-13 | Eingeleitet | Goldman | Neutral |
2021-09-08 | Bestätigt | JP Morgan | Overweight |
2021-09-07 | Bestätigt | Atlantic Equities | Overweight |
2021-07-21 | Bestätigt | Credit Suisse | Outperform |
2021-07-21 | Bestätigt | Deutsche Bank | Buy |
2021-07-21 | Bestätigt | JP Morgan | Overweight |
2021-07-21 | Bestätigt | KeyBanc Capital Markets | Overweight |
2021-07-21 | Bestätigt | Stifel | Buy |
2021-06-25 | Hochstufung | Credit Suisse | Neutral → Outperform |
2021-06-25 | Eingeleitet | Edward Jones | Hold |
2021-05-19 | Fortgesetzt | Jefferies | Buy |
2021-04-21 | Fortgesetzt | Oppenheimer | Outperform |
2021-04-21 | Bestätigt | Pivotal Research Group | Buy |
2021-04-21 | Hochstufung | Stifel | Hold → Buy |
2021-04-06 | Fortgesetzt | Evercore ISI | Outperform |
2021-04-01 | Eingeleitet | Piper Sandler | Overweight |
2021-03-25 | Bestätigt | The Benchmark Company | Sell |
2021-03-23 | Hochstufung | Argus | Hold → Buy |
2021-01-21 | Hochstufung | DZ Bank | Hold → Buy |
2021-01-20 | Bestätigt | Monness Crespi & Hardt | Buy |
2021-01-20 | Bestätigt | Pivotal Research Group | Buy |
2021-01-20 | Bestätigt | The Benchmark Company | Sell |
2021-01-20 | Hochstufung | UBS | Neutral → Buy |
2021-01-20 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
2020-10-21 | Bestätigt | BMO Capital Markets | Outperform |
2020-10-21 | Bestätigt | Bernstein | Outperform |
2020-10-21 | Bestätigt | Jefferies | Buy |
2020-10-21 | Bestätigt | Morgan Stanley | Overweight |
2020-10-21 | Bestätigt | Oppenheimer | Outperform |
2020-10-21 | Bestätigt | Piper Sandler | Overweight |
2020-10-21 | Bestätigt | Pivotal Research Group | Buy |
2020-10-21 | Bestätigt | RBC Capital Mkts | Outperform |
2020-10-21 | Bestätigt | The Benchmark Company | Sell |
2020-10-21 | Bestätigt | Wedbush | Underperform |
2020-10-21 | Bestätigt | Wells Fargo | Equal Weight |
2020-10-16 | Bestätigt | Morgan Stanley | Overweight |
2020-10-15 | Bestätigt | Canaccord Genuity | Buy |
2020-10-14 | Bestätigt | Goldman | Buy |
2020-10-07 | Bestätigt | Pivotal Research Group | Buy |
2020-09-28 | Bestätigt | The Benchmark Company | Sell |
2020-09-15 | Eingeleitet | KeyBanc Capital Markets | Overweight |
2020-09-09 | Fortgesetzt | Raymond James | Mkt Perform |
2020-09-04 | Bestätigt | The Benchmark Company | Sell |
2020-07-29 | Bestätigt | Loop Capital | Buy |
Alle ansehen
Netflix Inc Aktie (NFLX) Neueste Nachrichten
First Hawaiian Bank Decreases Stake in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
2 No-Brainer Media-Streaming Stocks to Buy Right Now - Yahoo Finance
MoffettNathanson Raises Price Target on Netflix to $1,300 From $1,150, Keeps Buy Rating - marketscreener.com
Netflix (NFLX) Price Target Raised by Citi Despite Neutral Outlo - GuruFocus
Life Line Wealth Management LLC Makes New $209,000 Investment in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
The Zacks Analyst Blog Highlights Netflix, Disney, Charter Communications, Roku and Roblox - Yahoo Finance
Hobart Private Capital LLC Purchases Shares of 295 Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Centre Asset Management LLC Invests $3.11 Million in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Fire Capital Management LLC Buys Shares of 395 Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Citigroup Adjusts Price Target on Netflix to $1,250 From $1,020, Maintains Neutral Rating - marketscreener.com
Mascagni Wealth Management Inc. Purchases New Position in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Ball & Co Wealth Management Inc. Invests $221,000 in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Former Netflix CEO Reed Hastings appointed to Anthropic’s board of directors - The Economic Times
Netflix breaks ground on $1 Billion movie studio in NJ - constructconnect.com
Netflix co-founder Reed Hastings joins board of AI company Anthropic - C21media
Netflix announces The Gentlemen season 2 with an unlikely new addition - The Independent
LM Advisors LLC Sells 750 Shares of Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Garde Capital Inc. Decreases Position in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
WNY Asset Management LLC Invests $237,000 in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Insider Selling: Netflix, Inc. (NASDAQ:NFLX) CAO Sells 640 Shares of Stock - MarketBeat
Insider Sell: Jeffrey Karbowski Sells 640 Shares of Netflix Inc (NFLX) - GuruFocus
Polar Asset Management Partners Inc. Grows Stake in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
B. Riley Wealth Advisors Inc. Sells 2,233 Shares of Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Universal Beteiligungs und Servicegesellschaft mbH Purchases New Position in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Pinnacle Wealth Planning Services Inc. Sells 556 Shares of Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Instrumental Wealth LLC Invests $209,000 in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Reese Witherspoon's company launches 'F1: The Academy' on Netflix focused on female drivers - The Tennessean
Netflix Co-Founder Reed Hastings Joins Anthropic’s Board By Stocktwits - Investing.com India
Netflix chairman Reed Hastings joins board of AI giant Anthropic - Los Angeles Times
Netflix Chairman Reed Hastings Appointed to Anthropic's Board - marketscreener.com
Former Netflix CEO Reed Hastings Joins Board of AI Company Anthropic - IMDb
Leanne Morgan Netflix Sitcom From EP Chuck Lorre Will Drop All 16 Episodes in July — See First Photos - IMDb
Netflix co-founder Reed Hastings joins Anthropic’s board - TechCrunch
Netflix co-founder and former CEO Reed Hastings joins Anthropic board By Reuters - Investing.com
Netflix co-founder and former CEO Reed Hastings joins Anthropic board - Reuters
Anthropic appoints Netflix Chairman Reed Hastings to AI startup's board of directors - CNBC
Anthropic Appoints Netflix Co-Founder Reed Hastings to Board - Bloomberg.com
Netflix co-founder joins Anthropic's board of directors (NFLX:NASDAQ) - Seeking Alpha
Netflix Co-Founder Reed Hastings Joins Board Of AI Firm Anthropic - Deadline
Netflix Founder Reed Hastings Joins Board of AI Giant Anthropic - IMDb
Netflix’s Reed Hastings Joins Board of AI Company Anthropic, a Rival to OpenAI - Yahoo
Anthropic Says Reed Hastings Appointed To Anthropic's Board Of Directors - marketscreener.com
'Sirens' Wasn’t Filmed Where You Think It Was - ELLE
Netflix announces The Gentlemen season 2 with the unlikely new addition - The Independent
Netflix’s The Gentlemen Reveals Full Season 2 Cast as Filming Begins in UK - IMDb
M1 Capital Management LLC Makes New Investment in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Netflix (NFLX) Options Trade Sees Significant Gains | NFLX Stock News - GuruFocus
DSG Capital Advisors LLC Invests $5.81 Million in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
PKO Investment Management Joint Stock Co Purchases Shares of 2,000 Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Lansforsakringar Fondforvaltning AB publ Invests $170.28 Million in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Centaurus Financial Inc. Buys 482 Shares of Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Finanzdaten der Netflix Inc-Aktie (NFLX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):